首页> 外文OA文献 >Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396

【2h】

Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396

机译：人免疫缺陷病毒1型成熟抑制剂PF-46396的构效关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

This work was funded by the University of St Andrews and Society for Applied Microbiology New Lecturer Research Grant awarded to CSA, Wellcome Trust grant (093228) awarded to TKS.

机译：这项工作由圣安德鲁斯大学和应用微生物学协会资助，CSA授予了新讲师研究资助，TKS授予了Wellcome Trust资助（093228）。

著录项

作者
Murgatroyd Christopher; Pirrie Lisa; Fanny Tran; Smith Terry K.; Westwood Nicholas J.; Adamson Catherine S.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4- fluoro-7-[1,2,3]triazol-1-yl-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-585248) [J] . Regueiro-Ren A., Xue Q.M., Swidorski J.J., Journal of Medicinal Chemistry . 2013,第4期

机译：1型人类免疫缺陷病毒（HIV-1）附着抑制剂。 12.与4-氟-6-氮杂吲哚衍生物相关的结构活性关系，导致鉴定1-（4-苯甲酰基哌嗪-1-基）-2-（4-氟-7- [1,2,3]三唑-1-基-1H-吡咯并[2,3-c]吡啶-3-基）乙烷-1,2-二酮（BMS-585248）
2. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. [J] . King PJ, Ma G, Miao W, Journal of Medicinal Chemistry . 1999,第3期

机译：构效关系：二咖啡酰奎尼酸和二咖啡酰酒石酸的类似物作为人类免疫缺陷病毒1型整合和复制的有效抑制剂。
3. Antiviral Activity, Safety, and Exposure-Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002) [J] . Hwang Carey, Schuermann Dirk, Sobotha Christian, Clinical infectious diseases . 2017,第3期

机译：GSK3532795，第二代人免疫缺陷病毒1型成熟抑制剂的抗病毒活性，安全性和暴露 - 响应关系，或者与在2A相2A的相2A中或没有Ritonavir的Atazanavir组合，用ritonavir组合随机，剂量范围，受控试验（ AI468002）
4. Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus Type 1 isolates in vitro [C] . S. RUSCONI, M. Lo CICERO, S. FERRAMOSCA, International School of Physics "Enrico Fermi" . 2007

机译：对人免疫缺陷病毒的非常规（折叠）蛋白酶抑制剂的易感性在体外1型分离物
5. Characterization of a Human Immunodeficiency Virus (HIV) Type I Integrase Inhibitor-Binding Pocket and Discovery of Novel Inhibitors Potent against Drug-Resistant Variants of HIV [D] . Crosby, David Charles 2010

机译：人类免疫缺陷病毒（HIV）I型整合酶抑制剂结合口袋的表征和新型抗HIV药物耐药变体的抑制剂的发现
6. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396 [O] . Christopher Murgatroyd, Lisa Pirrie, Fanny Tran, 2016

机译：人类免疫缺陷病毒1型成熟抑制剂PF-46396的构效关系
7. Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396 [O] . Murgatroyd, Christopher, Pirrie, Lisa, Fanny Tran, null, 2016

机译：人免疫缺陷病毒1型成熟抑制剂PF-46396的构效关系
8. Report on Carcinogens (RoC) Concept: Selected Viruses. Epstein--Barr Virus, Human ImmunodeficiencynVirus Type 1, Human T--Cell Lymphotropic Virus Type 1, Kaposi Sarcoma--Associated Herpes Virus, and nMerkel Cell Polyoma Virus. [R] . 2016

机译：关于致癌物（RoC）概念的报告：选定的病毒。爱泼斯坦 - 巴尔病毒，人类免疫缺陷病毒1型，人类T细胞淋巴细胞病毒1型，卡波西肉瘤 - 相关疱疹病毒和nmerkel细胞多瘤病毒。

Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅